Concord Drugs Fundamentals
P/E Ratio
51.97
P/B Ratio
2.15
Div. Yield
0
Sector P/E
41.56
Sector P/B
3.6
Sec. Div. Yield
0.5
Concord Drugs Fundamentals is currently trading with a P/E Ratio of 51.97, compared to the sector average of 41.56. Its P/B Ratio stands at 2.15, while the sector’s is 3.6. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.5%.
Concord Drugs Score Card
Price
Expensive
Growth
Good
Quality
Poor
Management
Poor
On its scorecard, Concord Drugs reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CONCORD
